In an era defined by rapid digital transformation, evolving patient expectations, and increasing system complexity, healthcare leadership is being fundamentally redefined. Bridging clinical practice with commercial strategy and policy insight, today’s leaders must navigate competing priorities while shaping sustainable, patient-centered models of care.

Divya Lal is a dynamic healthcare leader whose work sits at the intersection of clinical governance, government relations, and commercial strategy. With a strong focus on innovation and workforce development, she has been instrumental in designing scalable, nationally implemented programs that empower pharmacists across all stages of their careers. Recognised for her strategic foresight and collaborative approach, Divya continues to shape the future of healthcare by driving initiatives that enhance clinical outcomes, strengthen professional capability, and deliver sustainable impact across the sector.

In this interview, we explore her perspectives on leadership, innovation, and the evolving landscape of healthcare, along with the principles that guide her approach to building impactful programs and partnerships.

You actively mentor and teach emerging professionals—what skills or mindsets do you

think are critical for the next generation of healthcare leaders?

The future of healthcare leadership will require a robust blend of clinical credibility,

strategic vision, and commercial awareness. Leaders must possess deep expertise in

clinical practice while understanding the complexities of funding models, workforce

dynamics, and sustainable service scaling. As digital healthcare continues to transform

the healthcare sector – with advances such as electronic prescribing, real-time data

sharing, and automation in dispensing – proficiency in digital and AI technologies is

essential. Leaders must demonstrate data literacy, the ability to interpret AI-driven

insights, challenge their outputs, and integrate these tools safely into clinical practice.

Equally vital is the ability to adopt systems thinking, recognising how decisions impact

the broader care continuum and anticipating downstream effects across the healthcare

system. Strong stakeholder influence is required, enabling leaders to align pharmacists,

prescribers, allied health practitioners and technology partners around integrated,

patient-centred models of care. Effective governance and clinical oversight are

fundamental to ensure safety, efficiency, and accountability as new technologies are

implemented.

Innovation and adaptability are critical mindsets for future leaders. They must be

curious, digitally forward-thinking, and able to expand on their traditional roles.

Commercial awareness must be balanced with a commitment to enhancing outcomes,

access, and experience. Ultimately, the most impactful healthcare leaders will bridge

clinical excellence, strategic execution, and digital innovation, positioning them as a

central and scalable pillar in the evolving landscape of healthcare delivery.

Having worked extensively with diverse stakeholders, what are the key ingredients to

building effective, long-term strategic partnerships in healthcare?

Building effective, long-term strategic partnerships in healthcare hinges on several key

ingredients. First and foremost, open and transparent communication is vital to ensure

all parties are aligned and able to address challenges collaboratively. Establishing

shared goals and values helps foster mutual trust and a sense of common purpose,

which is essential for enduring relationships.

Additionally, flexibility and adaptability are crucial, as the healthcare landscape is

constantly evolving due to regulatory changes, technological advancements, and

shifting patient needs. Regular evaluation and feedback mechanisms allow for

continuous improvement and strengthen the partnership. Finally, commitment to

ethical practices and respect for each stakeholder’s expertise and contributions

underpin the success of any strategic alliance in healthcare.

You were featured in CEO Magazine’s “Women of Influence” spotlight—what does the theme “Balance the Scales” mean to you in the context of leadership today?

My call to action for every leader this International Women’s Day is simple but not

easy: move beyond intention and take structural action. This year’s theme of balancing

the scales demands more than symbolic support; it requires deliberate redesign of the

systems that shape opportunity. Do not just encourage women to be confident – design

environments where they are genuinely safe to be heard. Do not just celebrate potential

– build clear, funded pathways that convert that potential into authority, influence, and

decision-making power. Do not just talk about inclusion – measure it, resource it, and

hold leaders accountable for it.

Balancing the scales means shifting from access to equity. It means recognising that

advancing women in leadership is not a social initiative, it is a performance strategy.

Organisations that fully leverage the capability, perspective, and leadership of women

make better decisions, build stronger cultures, and deliver more sustainable

outcomes. So, do not just open doors. Change who holds the keys and redesign the

building so that leadership is not inherited by default, but earned through inclusive,

equitable systems that allow the best talent to rise.

You’re known for identifying emerging opportunities—how do you stay ahead of market

trends in such a dynamic and regulated industry?

Staying ahead of market trends in a dynamic and highly regulated industry requires a

proactive and multifaceted approach. I prioritise the regular review of industry reports,

participation in conferences, and ongoing engagement with sector experts to remain

informed and gain contemporary insights. In parallel, I closely monitor regulatory

developments and utilise data analytics to identify early shifts in consumer behaviour.

This combination of continuous learning and strategic networking enables the early

identification of emerging opportunities, supporting timely adaptation and the

maintenance of a competitive advantage.

In addition, I draw on international market analysis to examine diverse populations,

demographics, healthcare systems, and evolving clinical trends, which helps inform

forward-looking perspectives. Engagement with government ministers and

representatives, as well as academics and university students, further contributes to a

broader understanding of emerging priorities and future directions. This, in turn,

enables me not only to anticipate and respond to change effectively, but also to

contribute to shaping industry evolution and inform policy development in a meaningful

and considered manner.

Can you walk us through the journey of developing the nationally implemented,

revenue-generating program for pharmacists in Australia? What made it successful?

Developing a nationally implemented, revenue-generating program for pharmacists in

Australia typically begins with identifying a clear, scalable opportunity at the

intersection of clinical need and commercial viability. The process involves a thorough

analysis of existing gaps within the industry, informed by active engagement with pharmacists, pharmacy students, universities, patients, and insights derived from

personal practical, on-the-ground experience.

This approach was applied in the development of my educational initiative – the

program is designed for pharmacy students across all years of university and is

grounded in the practical competencies required upon graduation. Rather than relying

solely on skills being acquired during the intern year, the program is structured around

recognised pharmacy competency standards, enabling students to progressively

develop core practical and professional capabilities from their first year onward. The

student program subsequently transitions into an intern support component, which

continues to emphasise practical, practice-ready skills that are not typically covered in

depth within university curricula. This phase was developed in collaboration with key

industry leaders and academic institutions to ensure relevance and alignment with

workforce needs.

The final component of the program provides a structured pathway towards pharmacy

ownership, incorporating education in business management and financial literacy to

better equip pharmacists for leadership and ownership roles within the sector.

The course was established in response to identified gaps in education and

professional development across students, interns, and early-career pharmacists. It

also addresses broader workforce needs by strengthening the pipeline of capable

graduates, better preparing interns for clinical responsibility, equipping pharmacists to

assume roles such as pharmacist-in-charge, and supporting those who may progress

into ownership or partnership positions.

Through sustained engagement with industry bodies, universities, and key

stakeholders, the program has demonstrated success since its inception. More

broadly, successful programs of this nature are characterised by simplicity, scalability,

and sound commercial foundations, supported by continuous stakeholder

collaboration and the adaptability to evolve in response to regulatory changes and

advancements in digital health.

Your work sits at the intersection of government relations, clinical governance, and

commercial strategy—how do you balance competing priorities across these domains?

Balancing government relations, clinical governance, and commercial strategy requires

an integrated perspective that recognises these domains as interdependent rather than

competing priorities. It is essential to maintain a clear understanding of each domain’s

objectives and to actively identify areas of alignment and common ground. I approach

decision-making by first grounding all considerations in clinical integrity and patient

safety, ensuring adherence to established standards, regulatory requirements, and

evidence-based practice. From this foundation, I incorporate government and policy

contexts to ensure initiatives are compliant, forward-looking, and aligned with broader

health system objectives. Commercial considerations are then integrated in a manner

that supports sustainability and scalability without compromising clinical or regulatory

obligations.To manage competing priorities effectively, I prioritise structured collaboration and

robust governance frameworks that bring clinical, policy, and commercial perspectives

together early in the decision-making process. This is supported by maintaining open

and transparent communication with stakeholders, ensuring that regulatory

compliance and patient safety remain central while aligning these priorities with

commercial objectives. Through ongoing engagement with government stakeholders,

regulators, and industry partners, I ensure strategies remain responsive to evolving

policy environments. Regular reassessment of strategies, informed by data-driven

insights and stakeholder input, enables the proactive navigation of tensions and

supports informed decision-making. This approach facilitates outcomes that are

commercially viable, clinically sound, and consistent with government priorities,

ultimately supporting both organisational growth and the broader public interest.

By Nidhi Kumari